XML 20 R4.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Comprehensive Income - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Statement Of Income And Comprehensive Income [Abstract]      
Sales (note 22) $ 19,374,904 $ 510,624 $ 246,053
Cost of sales 1,072,221 67,180 32,469
Gross profit 18,302,683 443,444 213,584
Selling, general and administrative expenses (including rent expenses incurred to a related party of 2021 - $851, 2020 - $798, 2019 - $811) (note 12(b)) 591,167 176,534 121,468
Provision (recovery) for doubtful accounts 2,967 2,640 (306)
Research and development expenses 155,040 48,760 24,254
Loss on disposal of property, plant and equipment (note 7) 977 163 294
Government grants recognized in income (725) (297) (688)
Total operating expenses 749,426 227,800 145,022
Operating income 17,553,257 215,644 68,562
Interest and financing expenses – (including interest expenses incurred to a related party, 2021 - $916, 2020 - $663, 2019 - $455) (note 12(a)) (2,836) (1,453) (650)
Interest income 102,568 1,930 1,996
Other income (expense), net (89,948) 496 912
Income before income taxes 17,563,041 216,617 70,820
Income tax expense (note 14) (3,104,130) (31,438) (5,605)
Net income 14,458,911 185,179 65,215
Less: Income attributable to non-controlling interests (5,991,431) (74,810) (20,286)
Net income attributable to shareholders of Sinovac 8,467,480 110,369 44,929
Preferred stock dividends (5,982) (6,015) (5,128)
Net income attributable to common shareholders of Sinovac 8,461,498 104,354 39,801
Other comprehensive income, net of tax of nil      
Foreign currency translation adjustments 193,098 32,328 (2,827)
Comprehensive income 14,652,009 217,507 62,388
Less: comprehensive income attributable to non-controlling interests (6,073,832) (82,892) (19,681)
Comprehensive income attributable to shareholders of Sinovac $ 8,578,177 $ 134,615 $ 42,707
Earnings per share (note 21)      
Basic net income per share $ 85.20 $ 1.06 $ 0.42
Diluted net income per share $ 74.27 $ 0.97 $ 0.41
Weighted average number of shares of common stock outstanding      
– Basic 99,311,551 98,897,345 94,876,946
– Diluted 114,005,983 113,662,362 109,691,959